Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmastectomy angiosarcoma.

M B Martin, N D Kon, E H Kawamoto

    The American Surgeon
    |October 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia.

    Leukemia·2012
    Same author

    Endometriosis in association with pregnancy.

    American journal of obstetrics and gynecology·2010
    Same author

    The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.

    Clinical pharmacology and therapeutics·2010
    Same author

    [Anesthesia in interventional neuroradiology].

    Revista espanola de anestesiologia y reanimacion·2009
    Same author

    New image compression techniques using multiwavelets and multiwavelet packets.

    IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2008
    Same author

    TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations.

    Leukemia·2007
    Same journal

    Complete Response of Merkel Cell Carcinoma to Immunotherapy and Single-Fraction Radiotherapy Following Severe COVID-19 Infection: A Case Report and Review of Immune Mechanism.

    The American surgeon·2026
    Same journal

    Perioperative Acute Myocardial Infarction in Non-Cardiac Operations: A National Analysis.

    The American surgeon·2026
    Same journal

    Outcomes of Completion Cholecystectomy: Association With Patient Comorbidity in a National Database.

    The American surgeon·2026
    Same journal

    Building the Conversation: Editorial Stewardship in Contemporary Surgical Publishing.

    The American surgeon·2026
    Same journal

    Musculoskeletal Pain in Surgeons on Operating Days.

    The American surgeon·2026
    Same journal

    Splenectomy During Cytoreductive Surgery: Marker of Surgical Burden or Independent Predictor of Morbidity?

    The American surgeon·2026
    See all related articles

    Postmastectomy angiosarcoma, a rare cancer, often follows breast cancer treatment. Early detection and interscapulothoracic amputation are crucial for survival, as other treatments showed poorer outcomes.

    Area of Science:

    • Oncology
    • Surgical Oncology
    • Lymphedema Research

    Background:

    • Postmastectomy angiosarcoma is a rare but aggressive malignancy.
    • It can develop years after breast cancer treatment, including ductal carcinoma and Paget's disease.

    Purpose of the Study:

    • To review cases of postmastectomy angiosarcoma of the upper extremity.
    • To evaluate treatment outcomes and recommend optimal management strategies.

    Main Methods:

    • Retrospective review of six patients treated over 25 years.
    • Analysis of patient history, treatment modalities, and survival data.

    Main Results:

    • All six patients presented with significant upper extremity lymphedema preceding angiosarcoma.

    Related Experiment Videos

  • Interscapulothoracic amputation resulted in a 2-year survival, while wide excision or radiotherapy led to a mean survival of 4.5 years post-treatment.

    • Conclusions:

    • Lymphedema is a critical precursor, emphasizing careful lymphatic system preservation during mastectomy.
    • Interscapulothoracic amputation is recommended as the primary treatment for postmastectomy angiosarcoma of the upper extremity.